{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:31:19Z","timestamp":1791261079450,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872789"],"award-info":[{"award-number":["81872789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018-YF05-00004-SN"],"award-info":[{"award-number":["2018-YF05-00004-SN"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004536","name":"Southwest Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004536","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108626","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:08:25Z","timestamp":1749035305000},"page":"108626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A novel designed fully peptide-based PROTAC, FPP29, demonstrates its potent cytotoxic effects to liver cancer HCCLM3 cells by targeting FOXM1"],"prefix":"10.1016","volume":"163","author":[{"given":"Shijie","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canquan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.108626_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbagrm.2011.09.004","article-title":"FOXM1: from cancer initiation to progression and treatment","volume":"1819","author":"Koo","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) Gene Regul. Mech."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108626_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/boc.202400012","article-title":"FOXM1 transcriptional regulation","volume":"116","author":"Li","year":"2024","journal-title":"Biol. Cell."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108626_bb0015","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/ncomms6165","article-title":"Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition","volume":"5","author":"Gormally","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108626_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","article-title":"FOXM1: a small fox that makes more tracks for cancer progression and metastasis","volume":"92","author":"Khan","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108626_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12885-016-2542-4","article-title":"Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas","volume":"16","author":"Maekawa","year":"2016","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108626_bb0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bcp.2012.10.013","article-title":"Targeting FOXM1 in cancer","volume":"85","author":"Halasi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108626_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.08.009","article-title":"FoxM1: repurposing an oncogene as a biomarker","volume":"52","author":"Nandi","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108626_bb0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4155\/fmc-2023-0118","article-title":"Advances in inhibitors of potential tumor target FOXM1","volume":"15","author":"Han","year":"2023","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108626_bb0045","article-title":"Small-molecule inhibitors targeting FOXM1: current challenges and future perspectives in cancer treatments","volume":"1878","author":"Raghuwanshi","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108626_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2016.12.029","article-title":"A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression","volume":"796","author":"Bi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108626_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10989-014-9409-9","article-title":"Expression and selection of human Foxm1c binding peptides and their inhibitions on MCF7 cancer cells","volume":"20","author":"Cui","year":"2014","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bioorg.2025.108626_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177246","article-title":"A novel peptide CP29L, selected from the phage displayed cyclic random heptapeptide library, demonstrates its potent inhibitory effects to liver cancer HCCLM3 cells by targeting FOXM1","volume":"989","author":"Hua","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108626_bb0065","first-page":"11","article-title":"E3 ligase ligand optimization of clinical PROTACs","author":"Jiang","year":"2023","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108626_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108626_bb0075","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/acs.chemrev.4c00595","article-title":"Protein-based degraders: from chemical biology tools to neo-therapeutics","volume":"125","author":"Ou","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108626_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108626_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115793","article-title":"Current advances and development strategies of orally bioavailable PROTACs","volume":"261","author":"Zeng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108626_bb0090","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1093\/bioinformatics\/btz185","article-title":"CABS-dock standalone: a toolbox for flexible protein\u2013peptide docking","volume":"35","author":"Kurcinski","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2025.108626_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"6892","key":"10.1016\/j.bioorg.2025.108626_bb0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","article-title":"Structural basis for the recognition of hydroxyproline in HIF-1\u03b1 by pVHL","volume":"417","author":"Hon","year":"2002","journal-title":"Nature"},{"issue":"5574","key":"10.1016\/j.bioorg.2025.108626_bb0105","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","article-title":"Structure of an HIF-1\u03b1-pVHL complex: hydroxyproline recognition in signaling","volume":"296","author":"Min","year":"2002","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.bioorg.2025.108626_bb0110","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1\u03b1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108626_bb0115","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.3390\/ijms23169038","article-title":"Membrane internalization mechanisms and design strategies of arginine-rich cell-penetrating peptides","volume":"23","author":"Hao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108626_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.159","article-title":"A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma","volume":"50","author":"Song","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108626_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100910","article-title":"Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein","volume":"297","author":"Frost","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2025.108626_bb0130","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41388-024-03119-9","article-title":"EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth","volume":"43","author":"Corbin","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108626_bb0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-022-02483-2","article-title":"Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108626_bb0140","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.7150\/thno.46985","article-title":"The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination","volume":"10","author":"Jin","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108626_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/0929867330666230130121822","article-title":"Peptide-based PROTACs: current challenges and future perspectives","volume":"31","author":"Huidan","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108626_bb0150","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbrc.2016.01.158","article-title":"Proteolysis targeting peptide (PROTAP) strategy for protein ubiquitination and degradation","volume":"470","author":"Zheng","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108626_bb0155","first-page":"11","article-title":"FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c","volume":"3","author":"Lam","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108626_bb0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-physchem-042018-052340","article-title":"Kinetics of drug binding and residence time","volume":"70","author":"Bernetti","year":"2019","journal-title":"Annu. Rev. Phys. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108626_bb0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/cancers16040756","article-title":"The promise of combination therapies with FOXM1 inhibitors for cancer treatment","volume":"16","author":"Merjaneh","year":"2024","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108626_bb0170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/bmt.14.33","article-title":"Resistance to HER2-targeted therapies: a potential role for FOXM1","volume":"3","author":"Peake","year":"2014","journal-title":"Breast Cancer Manage."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:57:12Z","timestamp":1776920232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"alternative-id":["S0045206825005061"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108626","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel designed fully peptide-based PROTAC, FPP29, demonstrates its potent cytotoxic effects to liver cancer HCCLM3 cells by targeting FOXM1","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108626"}}